Outset Medical is a medical technology company. The Tablo® Hemodialysis System (Tablo) is cleared by the U.S. Food and Drug Administration for use from the hospital to the home. Tablo is designed to be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. The integration of water purification and dialysate production in a compact console enables Tablo to serve as a dialysis clinic on wheels. With a touchscreen interface, two-way wireless data transmission and a proprietary data analytics platform, Tablo is an approach to dialysis care. The Tablo system includes Tablo Console, Tablo Cartridge and Tablo Data Ecosystem components. The OM average annual return since 2020 is shown above.
The Average Annual Return on the OM average annual return since 2020 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether OM average annual return since 2020 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the OM average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|